Antheia to access Ginkgo’s enzyme screening and design technology

Ginkgo Bioworks, a Boston-based cell-programming specialist, will deploy its high-throughput enzyme design and screening technology to help the synthetic biology firm Antheia broaden its pipeline of drug active ingredients and starting materials.


Read the article at: https://cen.acs.org/business/biobased-chemicals/Antheia-access-Ginkgos-enzyme-screening/99/i30

0 comments